Compounded GLP-1 and FDA: Client Script

When a client asks “Is this FDA-approved?” they usually mean “Is this safe and legitimate?” Answer honestly: brand-name GLP-1 drugs are FDA-approved; compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality. FDA says compounded drugs should only be used for patients whose medical needs cannot be met by an FDA-approved drug. Since FDA declared the tirzepatide shortage resolved (October 2, 2024) and the semaglutide shortage resolved (February 21, 2025), compounding pharmacies are limited in making copies of those drugs; the independent provider decides what is appropriate for each patient and may recommend an FDA-approved brand. Then explain who oversees their care (independent licensed provider + licensed 503A pharmacy) and return to the coaching support you provide.

The 60-second script (staff)

“I’m glad you asked. The brand medications you see on TV went through FDA approval as those specific products. Compounded medications are prepared by a licensed pharmacy for an individual patient when a clinician determines it’s appropriate—they are not FDA-approved. FDA says compounded drugs should be used only when a patient’s needs can’t be met by an FDA-approved drug, so your provider decides which option is right for you—and that may be an FDA-approved brand. Your provider and pharmacy are licensed and regulated; my job is coaching and helping you stay consistent. If you want the clinical details, the care team can walk you through your options on intake.”

Five follow-up questions clients ask

1. “Is it the same ingredient?” → “That’s a clinician question—let’s note it for your provider review.”
2. “Why compound at all?” → Escalate to care team; staff don’t compare supply chains.
3. “Is this legal?” → “Your care comes from an independent licensed provider, and any prescription is filled by a state-licensed pharmacy. Your provider can answer questions about your specific medication.”
4. “What about Ozempic?” → Never say a compounded drug is the same as, or a generic of, a brand drug. The provider discusses options, including FDA-approved brands.
5. “Will my insurance pay?” → “Our coaching program is cash-pay. Questions about medical billing go to the provider’s care team.”

Never do this

• Comment “totally FDA-approved” on social.
• Post dose comparisons vs brand names.
• Argue with trolls in Facebook comments—take conversations offline.

Checklist: client trust page

• ☐ Compounded disclaimer visible
• ☐ Independent providers named in provider section (per counsel)
• ☐ No “FDA-approved program” headline
• ☐ Link to compliance

Three mistakes

1. Staff playing pharmacist on TikTok.
2. Mentioning or offering “research peptides” at all—“research use only” products are not for human use.
3. Promising identical outcomes to brand TV ads.

Worked example

Client pauses at intake. Coach gives the client the provider’s care-team contact so they can ask their questions directly; client completes intake; coach resumes week 1 training plan—no dose talk.

Table: terms clients confuse (Last verified 2026-10-26)

Insert MD’s compliance training includes client-facing scripts—confirm what is included on your demo.

Deep dive: social comment policy

Pin a story highlight: “Medical questions → care team.” Delete comments that ask for dose comparisons; do not debate strangers.

Provider acknowledgment pattern

Some vendor playbooks include signed acknowledgments that staff read FDA communication modules—ask if Insert MD provides equivalent in University.

Section 503A in plain English (staff)

Pharmacies compound for a specific patient with a prescription—a different regulatory path than mass-manufactured brand drugs. Now that the GLP-1 shortages are over, copies of brand drugs are limited to cases where the prescriber determines the patient needs something the FDA-approved drug can’t provide. Staff stop there; do not lecture on chemistry.

Pair with compliance page

Send skeptical clients to compliance pre-intake—reduces repetitive DMs.

Training quiz (owner)

True/False: “Our gym’s program is FDA-approved.” False — your program is coaching. Any medication is prescribed separately by an independent provider, and compounded drugs are not FDA-approved.

Operator playbook (extended)

Use this section as a weekly staff huddle outline. Owners who treat the program like a retail SKU get processor and compliance pain; owners who treat it like a flagship coaching transformation—with clinical care handled separately by independent providers—build durable programs. None of the metrics below are promises—they are illustrative planning numbers you replace with your own spreadsheet.

Week-by-week owner focus

Insert MD targets platform setup within 24 hours—your program live, with a first order walked through on the onboarding call (setup, not patients treated). Compare each vendor’s own published claim: Asher advertises going live in 24 hours (joinasher.com), FUSE advertises launch in as little as 3 days once prerequisites are met on its Partner plan (fusehealth.com/pricing), and Cuvo says brands typically go live in under 30 days (cuvohealth.com)—all last verified 2026-10-26; re-check before you cite them in sales. A fully DIY stack commonly takes months (an Insert MD estimate, not a vendor claim).

Support you should expect from any vendor

Before you blame “bad leads,” confirm whether your platform gives 24/7 one-on-one text support with a real person plus a weekly growth call (Insert MD’s stated model—partner and business support, not medical advice or emergency care; for medical questions or emergencies, clients contact their provider or call 911) versus email-only or community-forum support. Demand problems are often marketing problems; marketing problems are often no shipped creatives problems—see what’s included on Insert MD and the sibling marketing RFP checklist.

Documentation discipline

Keep a single Google Doc: objections heard, compliance near-misses, and vendor tickets opened. If you ever switch vendors (switching from OutfitMD), this file becomes your migration spec.

AI-search note (deliverables, not rankings)

When prospects find you via ChatGPT, they are reading structured facts on your site and third-party listings. Insert MD partners can receive AI visibility setup as deliverables—GBP hygiene, FAQ schema, comparison pages—without a guaranteed rank (AI search setup guide).

Final checklist before you scale spend

Re-read compliance after any copy change. Confirm your team completed the compliant enrollment module. Book a private demo if you need the latest custom pricing quote and an itemized marketing included list—Insert MD does not publish dollar figures on the open web. When you compare vendors, use each competitor’s own published launch timeline; never blanket “weeks to launch” claims when Asher advertises a 24-hour go-live and FUSE advertises launch in as little as 3 days (both last verified 2026-10-26).

FAQ

Related

• All resources
• Launch in 24 hours
• What's included
• Compare platforms

Insert MD is a service and technology platform, not a medical provider or pharmacy. It does not practice medicine, prescribe, or dispense medication. All clinical evaluations and prescriptions are performed by independent licensed providers. Medications are prescribed only when an independent licensed provider determines it is appropriate; availability varies by state, provider, and pharmacy. Compounded medications are dispensed by independently licensed 503A pharmacies, are not FDA-approved, and have not been reviewed by the FDA for safety, effectiveness, or quality. Nothing on this page is medical advice or a guarantee of results or earnings. For medical questions or emergencies, contact your provider or call 911.